You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NDC 46122-0735


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 46122-0735

Drug Name NDC Price/Unit ($) Unit Date
GNP ACID REDUCER 10 MG TABLET 46122-0735-75 0.09714 EACH 2025-01-22
GNP ACID REDUCER 10 MG TABLET 46122-0735-65 0.09714 EACH 2025-01-22
GNP ACID REDUCER 10 MG TABLET 46122-0735-75 0.09717 EACH 2024-12-18
GNP ACID REDUCER 10 MG TABLET 46122-0735-65 0.09717 EACH 2024-12-18
GNP ACID REDUCER 10 MG TABLET 46122-0735-75 0.09455 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 46122-0735

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 46122-0735

Understanding NDC Numbers

To delve into the market analysis and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what NDC numbers represent. NDC numbers are unique identifiers for medications, consisting of three segments: the labeler code, the product code, and the package code. These numbers facilitate accurate tracking, inventory management, and regulatory compliance within the pharmaceutical industry[1].

Identifying the Drug

The NDC number 46122-0735 corresponds to a specific medication, but the exact name and details of the drug are not provided in the sources. To proceed, one would typically refer to the National Drug Code Directory or similar resources to identify the drug, its strength, and formulation[5].

Market Trends and Pricing Factors

Several factors influence the pricing and market trends of pharmaceuticals, including the drug in question.

Specialty Pharmaceuticals

The pharmaceutical market is experiencing significant growth driven by specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions. According to Vizient, Inc., drug price inflation is projected to grow at 3.8%, with specialty pharmaceuticals being a major contributor to this increase. This trend suggests that drugs treating specific conditions, especially those with high demand and limited competition, may see price increases[4].

Biosimilars and Generic Drugs

The rise of biosimilars and generic drugs can impact the pricing of branded medications. Biosimilars, for instance, are expected to gain market share, which could lead to price competition and potentially lower prices for the original branded drugs. However, this effect may vary depending on the specific drug and market dynamics[4].

Regulatory and Economic Factors

Regulatory changes, economic uncertainties, and geopolitical factors can also influence drug pricing. For example, changes in US regulations, such as those related to the Inflation Reduction Act, and global regulatory shifts can impact how pharmaceutical companies price their products. Economic uncertainties and inflation can further complicate pricing strategies[3].

Price Projections

Given the general trends in the pharmaceutical market:

Projected Price Increase

For specialty pharmaceuticals, a price increase of around 4.18% is projected for 2024. If the drug identified by NDC 46122-0735 falls into this category, it could experience a similar price increase. However, this is speculative without specific details about the drug's classification and market position[4].

Impact of Biosimilars

If biosimilars for this drug are available or expected to enter the market, the price could stabilize or decrease slightly due to competition. However, biosimilars typically do not lead to drastic price reductions immediately, especially if they are not mandated at the payer level[4].

Regulatory and Economic Adjustments

Any significant regulatory changes or economic shifts could adjust the price projection. For instance, if there are changes in reimbursement policies or if the drug faces increased competition due to new market entrants, the price could be affected accordingly[3].

Example Pricing Scenario

Assuming the drug is a specialty pharmaceutical with moderate competition and no immediate biosimilar threat:

  • Current Price: Hypothetically, let's say the current price of the drug is $100 per unit.
  • Projected Increase: With a projected 4.18% increase for specialty pharmaceuticals, the new price could be approximately $104.18 per unit.
  • Regulatory and Economic Adjustments: If there are no significant regulatory changes or economic disruptions, this price increase might hold. However, any adverse changes could reduce the price increase or even lead to a price decrease.

Key Takeaways

  • NDC Numbers: Essential for tracking, inventory management, and regulatory compliance.
  • Market Trends: Specialty pharmaceuticals are driving price increases, while biosimilars may stabilize or reduce prices.
  • Regulatory and Economic Factors: Significant influences on pricing strategies.
  • Price Projections: A potential 4.18% increase for specialty pharmaceuticals, subject to market and regulatory conditions.

FAQs

Q: What is the significance of NDC numbers in the pharmaceutical industry? A: NDC numbers provide a standardized way to identify and track medications, aiding in inventory management, preventing medication errors, and ensuring regulatory compliance[1].

Q: How do biosimilars impact drug pricing? A: Biosimilars can stabilize or reduce prices by introducing competition, although the immediate impact may be minimal unless mandated at the payer level[4].

Q: What are the key factors influencing drug price projections? A: Key factors include market trends, regulatory changes, economic uncertainties, and the presence of biosimilars or generic drugs[3][4].

Q: How can pharmaceutical companies manage price increases effectively? A: Companies can manage price increases by optimizing supply chains, leveraging data-driven insights, and adapting to regulatory and market changes[1].

Q: What role do regulatory changes play in drug pricing? A: Regulatory changes can significantly impact pricing strategies by affecting reimbursement policies, competition, and market dynamics[3].

Sources

  1. Quality Smart Solutions: Why NDC Numbers are vital for pharmaceutical companies.
  2. Missouri Department of Social Services: Specialty MAC Name of Drug Strength NDC Price.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  5. HealthData.gov: National Drug Code Directory.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.